Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00902200 · ClinicalTrials.gov registry record · Phase 2
A Study of AR-12286 in Patient With Elevated Intraocular Pressure (IOP)
A Phase 2 study, sponsored by Aerie Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 89
- Enrollment target
NCT00902200 is a Phase 2 study that has completed, run by Aerie Pharmaceuticals. The registered enrollment target is 89 participants.
The verdict
NCT00902200, a Phase 2 study, has completed, sponsored by Aerie Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 89 participants
- Enrollment target
Study Summary
Double-masked, randomized, multi-center, placebo-controlled parallel-comparison of AR-12286.
Interventions
- DRUG AR-12286
- DRUG AR-12286 vehicle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2009-05 |
| Est. Completion | 2009-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00902200
The ClinicalTrials.gov registry entry for NCT00902200 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 89 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Aerie Pharmaceuticals, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which AR-12286 is the first listed.
NCT00902200 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00902200 about?
NCT00902200 is a clinical study titled "A Study of AR-12286 in Patient With Elevated Intraocular Pressure (IOP)". Double-masked, randomized, multi-center, placebo-controlled parallel-comparison of AR-12286.
What is the current status of trial NCT00902200?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 89 participants. The study started on 2009-05. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00902200?
The interventions under investigation include: AR-12286 (DRUG), AR-12286 vehicle (DRUG).
Who is sponsoring clinical trial NCT00902200?
This trial is sponsored by Aerie Pharmaceuticals, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.